Literature DB >> 3741255

Low-dose colchicine inhibits astrocyte, fibroblast, and retinal pigment epithelial cell migration and proliferation.

M Lemor, S de Bustros, B M Glaser.   

Abstract

We studied the effect of low-dose colchicine on cell proliferation and migration. Colchicine at doses well below the level of ocular toxicity was found to be a potent inhibitor of astrocyte, fibroblast, and retinal pigment epithelial (RPE) cell proliferation and migration. A colchicine concentration of 1.3 X 10(-8) mol/L, 10(-8) mol/L, and 1.7 X 10(-8) mol/L showed a 50% inhibition of proliferation for RPE, astrocytes, and fibroblasts, respectively. At 10(-7) mol/L, colchicine inhibited 44%, 46%, and 93% of RPE, astrocyte, and fibroblast migration, respectively. Low-dose colchicine appears to be an effective inhibitor of RPE, astrocyte, and fibroblast migration and proliferation in vitro.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741255     DOI: 10.1001/archopht.1986.01050200129066

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  11 in total

1.  Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits.

Authors:  S Kuriyama; T Ohuchi; N Yoshimura; Y Honda; M Hiraoka; M Abe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  The effect of X-ray irradiation on human retinal pigment epithelial cell proliferation.

Authors:  T Ohuchi; S Kuriyama; N Yoshimura; Y Honda; M Hiraoka; M Abe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

3.  Cytotoxic effects of antiproliferative agents on human retinal glial cells in vitro.

Authors:  J Cai; R Wei; X Ma; H Zhu; Y Li
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

Review 4.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

Review 5.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

Authors:  D G Charteris
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

Review 6.  Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

Authors:  M Weller; P Wiedemann; K Heimann
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

7.  HGAL inhibits lymphoma dissemination by interacting with multiple cytoskeletal proteins.

Authors:  Xiaoyu Jiang; XiaoQing Lu; Andrew J Gentles; Dekuang Zhao; Seth A Wander; Yu Zhang; Yasodha Natkunam; Joyce Slingerland; Isildinha M Reis; Brian Rabinovich; Midhat H Abdulreda; Vincent T Moy; Izidore S Lossos
Journal:  Blood Adv       Date:  2021-12-14

8.  Interferon-alpha 2b inhibits proliferation of human Tenon's capsule fibroblasts.

Authors:  M Gillies; T Su; M Sarossy; F Hollows
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-02       Impact factor: 3.117

9.  Polymeric Aqueous Biphasic System Rehydration Facilitates High Throughput Cell Exclusion Patterning For Cell Migration Studies.

Authors:  Hossein Tavana; Kerim Kaylan; Tommaso Bersano-Begey; Kathryn E Luker; Gary D Luker; Shuichi Takayama
Journal:  Adv Funct Mater       Date:  2011-05-24       Impact factor: 18.808

10.  Proliferative vitreoretinopathy: current and emerging treatments.

Authors:  Ama Sadaka; Gian Paolo Giuliari
Journal:  Clin Ophthalmol       Date:  2012-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.